Happy Holidays from Techsomed! As we embrace this festive season, we want to extend our warmest wishes to all our colleagues and partners. A heartfelt thank you to our team at Techsomed GmbH—May your holidays be filled with joy, warmth, and cherished moments with loved ones. Here’s to a prosperous New Year ahead, filled with new opportunities and continued success together! ✨ #techsomed #happyholidays
Techsomed
Medical Equipment Manufacturing
Rehovot עוקבים, Israel 1,652
Unlocking the true potential of Image Guided Ablation Therapy
עלינו
Techsomed is an Israeli based medical device company, developing ultrasound based real-time monitoring systems for thermal ablation procedures. The applications of thermal ablation are numerous: tumor destruction, heart arrhythmia, blood pressure treatments and more. The procedure has market size in the billions, but lacks real-time monitoring capabilities, causing high failure rates. Our technology offers added value to patients, physicians and insurance companies by solving the high failure rate of these minimally invasive and cost effective procedures.
- אתר אינטרנט
-
http://www.techsomed.com/
קישור חיצוני עבור Techsomed
- תעשייה
- Medical Equipment Manufacturing
- גודל החברה
- 11-50 עובדים
- משרדים ראשיים
- Rehovot, Israel
- סוג
- בבעלות פרטית
- הקמה
- 2012
- התמחויות
מיקומים
-
הראשי
2 Meir Weisgal St.
Rehovot, Israel 7632605, IL
עובדים ב- Techsomed
עדכונים
-
Unlock the Full Potential of Image-Guided Tumor Ablation Therapy! Techsomed is thrilled to showcase our innovative BioTraceIO360 Suite at RSNA2024. Join us at booth 5713 to discover how our solutions set a new standard in visualization for Image-Guided Therapy. Don’t miss the opportunity to explore cutting-edge advancements that can transform patient care. See you at RSNA! #RSNA2024 #TumorAblation #techsomed #imageguidedtherapy #BioTraceIO
-
Update from CIRSE 2024 in Lisbon 🌟 We extend our gratitude to Prof. Julius Chapiro from Yale School of Medicine for featuring our innovative AI-powered Image Guided Therapy solution during his talks at CIRSE 2024: "AI in Patient Selection and Treatment Planning in Interventional Radiology" and "Current Applications of AI in Daily Routine." Thank you, Prof. Chapiro, for highlighting our work and for sharing our vision of introducing AI-based innovation in interventional radiology! #techsomed, #biotrace, #imageguidedtherapy #CIRSE2024 #InterventionalRadiology #AI #Innovation #Healthcare
-
We are thrilled to share that we are attending the CIRSE 2024 Meeting in beautiful Lisbon! Join us to explore the latest innovations in Image-Guided #Ablation Therapy and discuss how we can push the boundaries of patient care together. If you're attending, let’s connect! We’d love to share insights and collaborate on advancing patient care. Looking forward to seeing you there! #CIRSE2024 #TumorAblation #InterventionalRadiology #Innovation #Networking
-
🎉 Exciting News! 🎉 We're thrilled to announce the U.S. launch of Techsomed's BioTraceIO Vision and BioTraceIO Precision software for image-guided ablation procedures! With FDA clearance and first clinical installations completed, these AI-powered solutions are set to revolutionize ablation therapy nationwide. Huge kudos to our amazing team for their dedication over the past 7+ years in developing these transformative technologies. Your hard work is truly making a difference! Kudos to everyone involved! 👏👏👏 #Techsomed #BioTraceIO #MedicalInnovation #AblationTherapy #HealthcareTechnology #FDAApproved #AIinMedicine #TeamSuccess https://lnkd.in/e9K-_FYP
-
🌟 We're excited to have participated as a sponsor at the 3rd Israeli Conference on Interventional Oncology and showcase the advanced capabilities of our BioTrace in unlocking the true potential of image-guided ablation therapy using our proprietary AI technology. A special thank you Dr. Michal Mauda-Havakuk for the opportunity to sponsor this event. It was a great opportunity to connect with the medical community and demonstrate how BioTrace can empower clinicians to achieve better patient outcomes through more accurate, personalized, and data-driven image-guided ablation therapy. #InterventionalOncology #AI #MedicalTechnology #BioTrace #Innovation #HealthcareTech #AblationTherapy
-
🌟 Excited for #SIR2024! Join us for a firsthand look at the future of image-guided ablation therapy technology. Want a private demo? Let us know! 🚀 Don't miss this chance to explore cutting-edge innovations in liver ablation with our team Yogev Zohar Dubi Finklshtein Inbal Amitai #Techsomed #LiverAblation #InnovationInHealthcare #InterventionalRadiology #PrecisionTherapy
-
Our sincere thanks to #israel21c for featuring #techsomed in a recent interview, showcasing our vision and mission in minimally invasive tumor ablation. We appreciate the opportunity to share our story and values with your audience! https://lnkd.in/d5WPiRKC #CompanySpotlight #livercancer #interventionalradiology #thermalablation #healthtech #medtech
AI-guided technique will be gamechanger for liver cancer - ISRAEL21c
israel21c.org
-
🌟 Join us at #SIR2024! 🌟 Interventional Radiologists, don't miss out on Techsomed’s professional symposium and educational breakfast! It's your exclusive opportunity to delve into the latest innovations in liver tumor ablation tissue response prediction. Experience firsthand our FDA de-novo cleared software, seamlessly integrating real-time ultrasound imaging to provide cutting-edge post-ablation tissue response prediction. Explore our groundbreaking 3D quantitative assessment of ablative margins, showcasing its correlation with 1-Year outcomes, backed by compelling new evidence. Date: Monday, March 25 2024 Time: 7:30 AM Location: Courtyard Hotel Downtown, Salt Lake City Register here: https://lnkd.in/eAwYVdDZ #interventionalradiology #ablation #thermalablation #HCC #livercancer #minimallyinvasive #biotraceio
-
🌟Exciting News! 🌟 We're thrilled to share a newly published article using our BioTrace software to reveal fascinating insights into the dynamic nature of post-ablation tissue response. Led by Dr. Sadeer Alzubaidi and his team at Mayo Clinic, the study showcases a consistent increase in ablation zone volume from immediate to 24-hour post-liver tumor ablation, shedding new light on tissue response post-treatment. This provides significant evidence supporting the value of using #BioTraceIO, our post-ablation tissue response prediction software for liver tumor ablation. We're proud to be at the forefront of medical innovation, empowering healthcare professionals with cutting-edge tools to enhance patient care and outcomes. Stay tuned for more exciting announcements as we continue to innovate ablation therapy. View the full article: https://lnkd.in/dJmxwS-M #interventionalradiology #abdominalradiology #ablationzone #thermalablation #healthtech #medtech